NCT01370512View on ClinicalTrials.gov

Droxidopa / Pyridostigmine in Orthostatic Hypotension

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Orthostatic Hypotension
Interventions
DRUG

Droxidopa

100 mg tablets by mouth three times a day

DRUG

Pyridostigmine

60 mg tablets by mouth three times a day

OTHER

Placebo

Looks exactly like the study drug but contains no active ingredients

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

Mayo Clinic

OTHER